MARATTO

article · AlQalam Journal of Medical and Applied Sciences

Anti-Ulcerogenic and Toxicological Evaluation of Polyphenol Rich Extract of Cochlospermum Planchonii Roots in Tissues of Aspirin-Induced Ulcerogenic Rats

2024Open accessUniversity of Ilorin

Abstract

The folkloric use of Cochlospermum planchonii roots as an anti-ulcerogenic and its safety is yet to be affirmed with scientific confirmation and this study is designed to do that. This study evaluated the anti-ulcerogenic activity and safety of polyphenol rich extract of Cochlospermum planchonii (PRECPR) roots in aspirin-induced ulcerogenic rats. These roots were processed to give dosages of 50, 100 and 150 mg/kg bodyweight. Thirty rats (138.0 ± 5.0 g) were assigned into six groups. Rats in group A (control) received 1.0 ml of distilled water. Those in groups B – F were administered 200 mg/kg body weight of aspirin and then treated with 1.0 ml of distilled water, 1.0 ml equivalent to 0.05 mg/kg body weight of omeprazole, 50, 100 and 150 mg/kg body weight of PRECPR, respectively. PRECPR dose-dependently increased (p > 0.05) nitric oxide, pH, activities of enzymes, concentrations of bilirubin, creatinine, haematological indices and decreased pepsinogen, volume and acidity of the gastric juice significantly. These results compared favourably (p < 0.05) with those of omeprazole treated group. This study provided strong indication that this extract could serve as an anti-ulcerogenic agent that is safe.

Research topics

  • Natural Antidiabetic Agents Studies
  • Drug-Induced Hepatotoxicity and Protection
  • Ethnobotanical and Medicinal Plants Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.54361/ajmas.2472012

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.